Publications of A. Ullrich
All genres
Journal Article (154)
141.
Journal Article
277 (33), pp. 29503 - 29509 (2002)
Phosphotyrosine-specific phosphatase PTP-SL regulates the ERK5 signaling pathway. Journal of Biological Chemistry 142.
Journal Article
76 (16), pp. 8124 - 8137 (2002)
Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein. Journal of Virology 143.
Journal Article
21 (32), pp. 4932 - 4943 (2002)
Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma. Oncogene 144.
Journal Article
295 (3), pp. 695 - 701 (2002)
Helicobacter pylori-stimulated EGF receptor transactivation requires metalloprotease cleavage of HB-EGF. Biochemical and Biophysical Research Communications 145.
Journal Article
62 (12), pp. 3402 - 3407 (2002)
A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Cancer Research 146.
Journal Article
36 (3), pp. 376 - 384 (2002)
Molecular portrait of human kidney carcinomas: The cDNA microarray profiling of kinases and phosphatases involved in the cell signaling control. Molecular Biology 147.
Journal Article
62 (9), pp. 2535 - 2539 (2002)
Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Research 148.
Journal Article
1 (2), pp. 117 - 123 (2002)
Smart drugs: Tyrosine kinase inhibitors in cancer therapy. Cancer Cell 149.
Journal Article
62 (3), pp. 840 - 847 (2002)
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Research 150.
Journal Article
41 (2), pp. 603 - 608 (2002)
The protein-tyrosine-pbosphatase SHP2 is phosphorylated on serine residues 576 and 591 by protein kinase C Isoforms alpha, beta 1, beta 2, and eta. Biochemistry 151.
Journal Article
8 (10), pp. 391 - 396 (2002)
Unstable receptors disappear from cell surface during poliovirus infection. Medical Science Monitor 152.
Journal Article
63 (Suppl. 1), pp. 1 - 5 (2002)
Molecular targets in cancer therapy and their impact on cancer management. Oncology 153.
Journal Article
8 (1), pp. 17 - 23 (2002)
Receptor tyrosine kinases as targets for anticancer drugs. Trends in Molecular Medicine 154.
Journal Article
382 (12), pp. 1649 - 1662 (2001)
Mig-6 is a negative regulator of the epidermal growth factor receptor signal. Biological Chemistry Conference Paper (1)
155.
Conference Paper
FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. ASCO Annual Meeting, 2006. Meeting Abstracts, p. 34S - 34S (2006)
Meeting Abstract (8)
156.
Meeting Abstract
50 (Suppl. 5), 791, pp. S190 - S191. ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND (2014)
Investigation of the mode of action of sunitinib kinase inhibitor profile analogues in insulin release. In EUROPEAN JOURNAL OF CANCER, 157.
Meeting Abstract
50 (Suppl. 5), 632, p. S151 - S151. ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND (2014)
Tamoxifen resistance can be overcome by salinomycin treatment. In EUROPEAN JOURNAL OF CANCER, 158.
Meeting Abstract
50 (Suppl. 5), 417, pp. S99 - S100. ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND (2014)
Visualization of tumor formation in the WAP-TGFa/FGFR4Arg385 KI breast cancer mouse model. In EUROPEAN JOURNAL OF CANCER, 159.
Meeting Abstract
50 (Suppl. 5), 801, pp. S193 - S194. ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND (2014)
Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors - suggestion of combination therapy. In EUROPEAN JOURNAL OF CANCER, 160.
Meeting Abstract
50 (Suppl. 5), 446, pp. S107 - S108. ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND (2014)
A gain of function by the cancer-associated FGFR4 c. 1162G>A (p. Gly388Arg) variant. In EUROPEAN JOURNAL OF CANCER,